Related references
Note: Only part of the references are listed.Striatal dopaminergic alterations in individuals with copy number variants at the 22q11.2 genetic locus and their implications for psychosis risk: a [18F]-DOPA PET study
Maria Rogdaki et al.
MOLECULAR PSYCHIATRY (2023)
Reproducing the dopamine pathophysiology of schizophrenia and approaches to ameliorate it: a translational imaging study with ketamine
Michelle Kokkinou et al.
MOLECULAR PSYCHIATRY (2021)
A potential biomarker for treatment stratification in psychosis: evaluation of an [18F] FDOPA PET imaging approach
Mattia Veronese et al.
NEUROPSYCHOPHARMACOLOGY (2021)
Effects of administration route on uptake kinetics of 18F-sodium fluoride positron emission tomography in mice
Zaniah N. Gonzalez-Galofre et al.
SCIENTIFIC REPORTS (2021)
Dopamine and glutamate in individuals at high risk for psychosis: a meta-analysis of in vivo imaging findings and their variability compared to controls
Robert A. McCutcheon et al.
WORLD PSYCHIATRY (2021)
Determinants of treatment response in first-episode psychosis: an 18F-DOPA PET study
Sameer Jauhar et al.
MOLECULAR PSYCHIATRY (2019)
The relationship between cortical glutamate and striatal dopamine in first-episode psychosis: a cross-sectional multimodal PET and magnetic resonance spectroscopy imaging study
Sameer Jauhar et al.
LANCET PSYCHIATRY (2018)
Single cocaine exposure does not alter striatal pre-synaptic dopamine function in mice: an [18F]-FDOPA PET study
David R. Bonsall et al.
JOURNAL OF NEUROCHEMISTRY (2017)
Elevated Striatal Dopamine Function in Immigrants and Their Children: A Risk Mechanism for Psychosis
Alice Egerton et al.
SCHIZOPHRENIA BULLETIN (2017)
A Test of the Transdiagnostic Dopamine Hypothesis of Psychosis Using Positron Emission Tomographic Imaging in Bipolar Affective Disorder and Schizophrenia
Sameer Jauhar et al.
JAMA PSYCHIATRY (2017)
Regulation of dopaminergic function: an [18F]-DOPA PET apomorphine challenge study in humans
S. Jauhar et al.
TRANSLATIONAL PSYCHIATRY (2017)
Effects of Smoking Cessation on Presynaptic Dopamine Function of Addicted Male Smokers
Lena Rademacher et al.
BIOLOGICAL PSYCHIATRY (2016)
A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research
Terry K. Koo et al.
JOURNAL OF CHIROPRACTIC MEDICINE (2016)
Evaluation of Inhibitory Effect of Recreational Drugs on Dopaminergic Terminal Neuron by PET and Whole-Body Autoradiography
Skye Hsin-Hsien Yeh et al.
BIOMED RESEARCH INTERNATIONAL (2014)
The Molecular Mechanism of Intestinal Levodopa Absorption and Its Possible Implications for the Treatment of Parkinson's Disease
Simone M. R. Camargo et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
In-vivo measurement of LDOPA uptake, dopamine reserve and turnover in the rat brain using [F-18]FDOPA PET
Matthew D. Walker et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2013)
Striatal Presynaptic Dopamine in Schizophrenia, Part II: Meta-Analysis of [18F/11C]-DOPA PET Studies
Paolo Fusar-Poli et al.
SCHIZOPHRENIA BULLETIN (2013)
Dopamine Synthesis Capacity Before Onset of Psychosis: A Prospective [18F]-DOPA PET Imaging Study
Oliver D. Howes et al.
AMERICAN JOURNAL OF PSYCHIATRY (2011)
A longitudinal study of motor performance and striatal [18F]fluorodopa uptake in Parkinson's disease
Catherine L. Gallagher et al.
BRAIN IMAGING AND BEHAVIOR (2011)
Effects of Administration Route, Dietary Condition, and Blood Glucose Level on Kinetics and Uptake of 18F-FDG in Mice
Koon-Pong Wong et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Use of [F-18]FDOPA-PET for in vivo evaluation of dopaminergic dysfunction in unilaterally 6-OHDA-lesioned rats
Kiyoshi Kyono et al.
EJNMMI RESEARCH (2011)
The test-retest reliability of 18F-DOPA PET in assessing striatal and extrastriatal presynaptic dopaminergic function
Alice Egerton et al.
NEUROIMAGE (2010)
A Follow-Up Study on 6-[18F]Fluoro-L-dopa Uptake in Early Parkinson's Disease Shows Nonlinear Progression in the Putamen
Anna Bruck et al.
MOVEMENT DISORDERS (2009)
PET Studies of Cerebral Levodopa Metabolism: A Review of Clinical Findings and Modeling Approaches
Yoshitaka Kumakura et al.
NEUROSCIENTIST (2009)
Elevated [18F]fluorodopamine turnover in brain of patients with schizophrenia:: An [18F]fluorodopa/positron emission tomography study
Yoshitaka Kumakura et al.
JOURNAL OF NEUROSCIENCE (2007)
Asymmetry in dopamine D2/3 receptors of caudate nucleus is lost with age
Ingo Vernaleken et al.
NEUROIMAGE (2007)
Comparison of [18T]FDOPA, [18F]FMT and [8F]FECNT for imaging dopaminergic neurotransmission in mice
Michael Honer et al.
NUCLEAR MEDICINE AND BIOLOGY (2006)
Complex-1 activity and 18F-DOPA uptake in genetically engineered mouse model of Parkinson's disease and the neuroprotective role of coenzyme Q10
Sushil K. Sharma et al.
BRAIN RESEARCH BULLETIN (2006)
Presynaptic dopaminergic dysfunction in schizophrenia -: A positron emission tomographic [18F]fluorodopa study
S McGowan et al.
ARCHIVES OF GENERAL PSYCHIATRY (2004)
Micro-PET imaging and small animal models of disease
HR Herschman
CURRENT OPINION IN IMMUNOLOGY (2003)
Subchronic haloperidol downregulates dopamine synthesis capacity in the brain of schizophrenic patients in vivo
G Gründer et al.
NEUROPSYCHOPHARMACOLOGY (2003)
Loss of metabolites from monkey striatum during PET with FDOPA
P Cumming et al.
SYNAPSE (2001)
A reversible tracer analysis approach to the study of effective dopamine turnover
V Sossi et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2001)
Share Paper
